BioMarin Pharmaceutical Inc (MIL:1BMRN)
€ 52.3 (0%) Market Cap: 11.66 Bil Enterprise Value: 14.54 Bil PE Ratio: 187.97 PB Ratio: 2.14 GF Score: 61/100

BioMarin Pharmaceutical Inc. at Canaccord Genuity Growth Conference Transcript

Aug 12, 2026 / 12:00PM GMT
Whitney Ijem
Canaccord Genuity Corp - Equity Analyst

All right. Good morning, everyone. Thank you so much for joining us. My name is Whitney Ijem. I am one of the biotech analysts here at Canaccord. And it's my pleasure to introduce BioMarin Pharmaceuticals this morning. And on behalf of BioMarin, we have Brian Mueller, CFO. Thank you for being here.

Questions & Answers

Whitney Ijem
Canaccord Genuity Corp - Equity Analyst

So just to start off high level for anybody who's not familiar, for anybody who that might be, I don't know, BioMarin is a household name. But for anybody who is not familiar, can you briefly introduce the story, like who is BioMarin currently? And where are you trying to go over the next 5-, 10 years?

Brian Mueller
BioMarin Pharmaceutical Inc. - Chief Financial Officer, Executive Vice President

Yes. Thanks, Whitney, for having us. Really glad to be here. Thanks, everyone, joining in person and those online. Yes. So I do think there are some folks that may not be familiar with BioMarin

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot